comparison of bupropion and ritaline in the treatment of children with ADHD
Phase 2
- Conditions
- Disturbance of activity and attention.Disturbance of activity and attention
- Registration Number
- IRCT201012021556N18
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Inclusion Criteria: Diagnosis of ADHD based on DSM-IV, age between 6-17
Exclusion Criteria
receiving of any psychotropics drugs during past two weeks, presence of any psychiatric disorders or mental retardation (I.Q. <70) except for ODD, History of Allergy to Bupropion, presence of any medical problem including cardiovascular dieseases, presence of uncontrolled seizures, systolic blood pressure>125, resting pulse rate <60/minute or >115/minute, zinc deficiency, lead intoxication
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of ADHD. Timepoint: Week 0 (before treatment) and Weeks 3 and 6 after treatment. Method of measurement: Teacher and Parent ADHD Rating Scale.
- Secondary Outcome Measures
Name Time Method